Research workbench
WELO5 G166D variant bound to FE(II), 2-oxoglutarate, and 12- epifischerindole U
Analyse WELO5 G166D variant bound to FE(II), 2-oxoglutarate, and 12- epifischerindole U in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 5IQU
- Type
- protein
- Length
- 267 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- WELO5
- UniProt
- A0A067YX61
- Ligands
- AKG, 6CU, FE2
- Pockets
- 1 · best druggability 0.70
Structure
x-ray diffraction · 1 distinct chain · 29% helix, 28% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | WELO5 | protein | 267 | 29% helix, 28% strand | A0A067YX61 |
Ligands and binding sites
- AKG · 2-oxoglutaric acid · ligand · chains A
- 6CU · (6aS,9R,10R,10aS)-9-ethyl-10-isocyano-6,6,9-trimethyl-5,6,6a,7,8,9,10,10a-octahydroindeno[2,1-b]indole · ligand · chains A
- FE2 · Fe (II) ion · metal · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 438 | 0.70 | 0.81 | 49 | FE2, AKG, 6CU |
Compared structures
- 5IQU · WelO5 G166D variant bound to Fe(II), 2-oxoglutarate, and 12-epifischerindole U · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt A0A067YX61
- Elsewhere: RCSB PDB 5IQU · PDBe 5IQU · UniProt A0A067YX61
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.